Survival of HIV-1 in syringes

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 1, 1999, Pages 73-80

  Abdala, Nadia ^a   Stephens, P Clay ^a   Griffith, Brigitte P ^a,b   Heimer, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

HIV 1 culture assays; HIV 1 viability; Injection drug use; Needle syringe exchange; Transmission

Indexed keywords

ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SURVIVAL TIME; SYRINGE; VIRUS RESISTANCE;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032924543     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199901010-00011     Document Type: Article

References (37)

1. Mann JM, Tarantola DJM. AIDS in the world II: global dimensions, social roots, and responses. New York: Oxford University Press, 1996.
2. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
3. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
4. Chaisson R, Moss A, Onishi R, Osmond D, Carlson J. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health 1987;77:169-72.
5. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for Human Immunodeficiency Virus infection in intravenous drug users. N Engl J Med 1989;321:874-9.
6. Agar MH. Into that whole ritual thing: ritualistic drug use among urban American heroin addicts. In Dutoit BM, ed. Drug rituals and altered states of consciousness. Rotterdam: Balkema, 1977:137-48.
7. Grund J-P, Kaplan CD, Adriaans NFP, Blanken P, Huisman J. The limitations of the concept of needle sharing: the practice of front-loading. AIDS 1990;4:819-21.
8. Normand J, Vlahov D, Moses LE., eds. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
9. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers -Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:82-9.
10. Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/ AIDS among injection drug users: a national survey on the regulation of syringes and needles. JAMA 1997;277:53-62.
11. Kaplan EH. A method for evaluating needle exchange programmes. Stat Med 1994;13:2179-87.
12. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl):S37-44.
13. Resnick L, Veren K, Salahuddin Z, Tondreau S, Markhman PD. Stability and inactivation of HTLV-III/LAV under clinical and experimental environments. JAMA 1986;255:1887-91.
14. Slade JS, Pike EB, Eglin RP, Colbourne JS, Kurtz JB. The survival of human immunodeficiency virus in water, sewage, and sea water. Water Sci Technol 1989;21:55-9.
15. Moudgil T, Daar ES. Infectious decay of human immunodeficiency virus type 1 in plasma. J Infect Dis 1993;167:210-12.
16. Newmeyer J, Drew L, Miner R. HIV transmission in simulated conditions of sharing of hypodermic equipment. J Acquir Immune Defic Syndr 1990;3:1019-21.
17. Shapshak P, McCoy CB, Shah SM, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J Acquir Immune Defic Syndr 1994;7:754-9.
18. Druce JD, Locarnini SA, Birch CJ. Syringe cleaning techniques and transmission of HIV. AIDS 1995;9:1105-7.
19. Hoffman PN, Larkin DP, Samuel D. Needlestick and needle-share - the difference. J Infect Dis 1989;160:545.
20. Gaughwin MD, Gowans E, Ali R, Burrell C. Bloody needles: the volume of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS 1991;5:1025-7.
21. Hollinger FB. ACTG virology manual for HIV laboratories. Bethesda, MD: Division of AIDS, NIAID, NIH, 1993.
22. Dimitrov DS, Willey RL, Sato H, Chang L-J, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virology 1993;67:2182-90.
23. Myers LE, McQuay LJ, Hollinger FB. Dilution assay statistics. J Clin Microbiol 1994;32:732-9.
24. Alimenti A, Luzuriaga K, Sullivan JL, Van den Borre C, Zissis G, Levy J. Quantitation of HIV-1 in whole blood of infected children. AIDS 1994;8:895-900.
25. Agar M. Ripping and running: a formal ethnography of urban heroin addicts. New York: Seminar Press, 1973.
26. Grund J-P, Stern LS. Residual blood in syringes: size and type of syringe are important. AIDS 1991;5:1532-3.
27. NIH Consensus Development Program. Interventions to prevent HIV risk behaviors. Bethesda, MD: National Institutes of Health, 1997.
28. Riley E, Beilenson P, Vlahov D, et al. Operation red box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J Acquir Immune Defic Syndr Human Retrovirol 1998;18(Suppl 1):S120-5.
29. Kaplan EH, Heimer R. A circulation theory of needle exchange. AIDS 1994;8:567-74.
30. Subbarao S, Schochetman G. Genetic variability of HIV-1. AIDS 1996;10(Suppl A):S13-23.
31. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271:324-8.
32. Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 1997;11(Suppl A):S3-16.
33. Gotch FM, Koup RA, Safrit JT. New observations on cellular immune response to HIV and T-cell epitopes. AIDS 1997;11(Suppl A):S99-107.
34. Masters B, Abrishami M, Farzadegan H. Recovery of HIV from syringes [abstract 23222]. Presented at the XII International AIDS Conference, Geneva, Switzerland, 1998.
35. Napoli V, McGowan JEJ. How much blood is in a needlestick? J Infect Dis 1987;155:828.
36. Sattar SA, Springthorpe VS. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev Infect Dis 1991;13:430-47.
37. Tjøtta E, Hungnes O, Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol 1991;35:223-7.